Atomoxetine is a selective norepinephrine reuptake inhibitor used to treat attention-deficit hyperactivity disorder (ADHD). Unlike stimulants, it does not increase dopamine levels, making it a good alternative for those at risk of substance misuse. It improves focus and reduces impulsivity and hyperactivity. Common side effects include dry mouth, insomnia, and decreased appetite.
Cleanchem is a trusted provider of premium pharmaceutical reference materials, specializing in Atomoxetine and its associated compounds. Our catalog includes pharmacopeial and non-pharmacopeial Atomoxetine impurities, metabolites, nitrosamine derivatives (N-NO compounds), and stable isotope-labeled products. These reference standards play a critical role in pharmaceutical R&D, supporting activities such as product formulation, ANDA and DMF submissions, quality assurance, analytical method development, and stability assessments.
All Atomoxetine-related substances undergo comprehensive characterization and are delivered with complete Certificates of Analysis and supporting analytical documentation to ensure regulatory adherence. Upon request, we can offer EP/USP traceable standards. Our products are routinely re-evaluated to maintain consistent quality and performance.
English
Arabic
Chinese (Simplified)
French
Japanese
Portuguese
Russian
Spanish
